Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What is the optimal cardiac screening for asymptomatic transthyretin gene mutation carriers?

× No keyword cloud information.

2 in total

1. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using ¹⁸F-Florbetapir PET/CT.

Authors: Ariana Nodoushani; Mohammed Samir El-Sady; Mi-Ae Park; Gloria L Castilloveitia; Rodney H Falk; Marcelo F Di Carli; Marie Foley Kijewski; Sharmila Dorbala
Journal: J Nucl Cardiol Date: 2019-11-22 Impact factor: 3.872

2 in total

4 in total

1. Diagnostic performance of F¹⁸ FDG PET in cardiac sarcoidosis: Are we getting closer to the truth?

Authors: Hayan Jouni; Panithaya Chareonthaitawee
Journal: J Nucl Cardiol Date: 2019-02-15 Impact factor: 5.952

2. Is quantitative fluorine-18 fluorodeoxyglucose PET image analysis the key to Identify cardiac sarcoidosis?

Authors: Richard C Brunken
Journal: J Nucl Cardiol Date: 2020-07-16 Impact factor: 5.952

3. ¹⁸F-FDG PET/CMR in cardiac sarcoidosis: A wild card in the deck?

Authors: Carmela Nappi; Andrea Ponsiglione; Massimo Imbriaco; Alberto Cuocolo
Journal: J Nucl Cardiol Date: 2020-11-03 Impact factor: 5.952

4. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/¹⁸F-fluorodeoxyglucose positron emission tomography examinations.

Authors: Toshikazu D Tanaka; Toshiyuki Nagai; Tomohisa Nagoshi; Michihiro Yoshimura
Journal: J Nucl Cardiol Date: 2019-11-26 Impact factor: 5.952

4 in total

What is the optimal cardiac screening for asymptomatic transthyretin gene mutation carriers?

1. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using 18F-Florbetapir PET/CT.

1. Diagnostic performance of F18 FDG PET in cardiac sarcoidosis: Are we getting closer to the truth?

2. Is quantitative fluorine-18 fluorodeoxyglucose PET image analysis the key to Identify cardiac sarcoidosis?

3. 18F-FDG PET/CMR in cardiac sarcoidosis: A wild card in the deck?

4. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/18F-fluorodeoxyglucose positron emission tomography examinations.

1. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using ¹⁸F-Florbetapir PET/CT.

1. Diagnostic performance of F¹⁸ FDG PET in cardiac sarcoidosis: Are we getting closer to the truth?

3. ¹⁸F-FDG PET/CMR in cardiac sarcoidosis: A wild card in the deck?

4. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/¹⁸F-fluorodeoxyglucose positron emission tomography examinations.